Oric Pharmaceuticals
ORIC
ORIC
90 hedge funds and large institutions have $291M invested in Oric Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 27 increasing their positions, 28 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
18% less capital invested
Capital invested by funds: $353M → $291M (-$62.7M)
24% less call options, than puts
Call options by funds: $216K | Put options by funds: $285K
Holders
90
Holding in Top 10
6
Calls
$216K
Puts
$285K
Top Buyers
| 1 | +$7M | |
| 2 | +$4.79M | |
| 3 | +$4.71M | |
| 4 |
Franklin Resources
San Mateo,
California
|
+$4.43M |
| 5 |
Alkeon Capital Management
New York
|
+$3.02M |
Top Sellers
| 1 | -$3.83M | |
| 2 | -$3.63M | |
| 3 | -$1.98M | |
| 4 |
O
OrbiMed
New York
|
-$1.66M |
| 5 |
PM
Prosight Management
Dallas,
Texas
|
-$1.1M |